MYX 3.29% $4.40 mayne pharma group limited

Some Analysis, page-78

  1. 1,371 Posts.
    lightbulb Created with Sketch. 263
    If Nextellis had any future at all Mithra
    share price like Mayne would not be falling
    off a Cliff. Our reps must be ramming it down
    users throats. OK short term but without repeat
    business It is a costly failure. The product obviously
    cannot stand up to scrutiny and hold its own.
    Everything associated with Mithra Pharma has been
    a financial disaster and an excruciatingly painful
    experience . I think we should completely disassociate
    ourselves from them. They’re purely a lip service
    company with nothing to back it up.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.